Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs
Energenesis has signed a development agreement with Taiwan Tanabe for its investigational topical drug ENERGI-F703DFU to treat DFUs.
Read the full article on the original site.
Read Full Article